The global next generation sequencing (NGS) library preparation automation market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing incidences of various diseases, rising demand for next-generation sequencing, and a rise in government initiatives, which are curbing the market's growth. Next-generation Sequencing (NGS) is a parallel processing technology that can establish the sequence of nucleotides in a whole genome with ultra-high capacity, scalability, and high speed. Next-generation sequencing (NGS) includes steps such as sample pre-processing, library preparation, sequencing, and bioinformatics. The library preparation process is crucial in NGS workflow but is very time-consuming due to the several repetitive steps requiring small volumes to be pipetted with high accuracy. The automation of library preparation can enhance efficiency, produce more steady results, and improve lab efficacy. The other factors supporting the market’s growth are, the extensive research and development, large number of clinical trials, increasing awareness, various government investments, the growing number of collaborations between companies to build library preparation protocols, and technological advancements.
Rising demand for Next Generation Sequencing
For instance, in 2018, the Centers for Medicare & Medicaid Services (CMS) stated the National Coverage Determination to carry out NSG tests to diagnose cancer.
Increasing Investments and R&D Activities
In 2022, total biotechnology financing by the National Institutes for Health was USD7,912 billion.
Market Segmentation
Market Players
Agilent Technologies, Inc., BGI Group, Aurora Biomed Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F.Hoffmann-La Roche AG, Eppendorf SE, Hamilton Company, Hologic Inc., Illumina Inc., Oxford Nanopore Technologies Limited, PerkinElmer, Inc., Promega Corporation, Takara Bio Inc., and QIAGEN NV
Attribute | Details |
Base Year | 2021 |
Historic Data | 2017 – 2020 |
Estimated Year | 2022 |
Forecast Period | 2023 – 2027 |
Quantitative Units | Revenue in USD Million, Volume Units and CAGR for 2017-2021 and 2022-2027 |
Report coverage | Revenue forecast, Volume forecast company share, competitive landscape, growth factors, and trends |
Segments covered | · Product · Sequencing Type · Application · End User · Company |
Regional scope | North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa |
Country scope | United States; Canada; Mexico; China; India; Japan; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; South Africa |
Key companies profiled | Agilent Technologies, Inc., BGI Group, Aurora Biomed Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F.Hoffmann-La Roche AG, Eppendorf SE, Hamilton Company, Hologic Inc., Illumina Inc., Oxford Nanopore Technologies Limited, PerkinElmer, Inc., Promega Corporation, Takara Bio Inc., and QIAGEN NV |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |